Analytical Data
-
Gene name
SPAG9
- Application
-
Alternative Names
(JIP-4)(JNK-interacting protein 4)(Cancer/testis antigen 89)(CT89)(Human lung cancer oncogene 6 protein)(HLC-6)(JNK-associated leucine-zipper protein)(JLP)(Mitogen-activated protein kinase 8-interacting protein 4)(Proliferation-inducing protein 6)(Protein highly expressed in testis)(PHET)(Sperm surface protein)(Sperm-associated antigen 9)(Sperm-specific protein)(Sunday driver 1)
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60271
-
Expression Region
408-534 aa
-
AA Sequence
REVENLILENTQLLETKNALNIVKNDLIAKVDELTCEKDVLQGELEAVKQAKLKLEEKNRELEEELRKARAEAEDARQKAKDDDDSDIPTAQRKRFTRVEMARVLMERNQYKERLMELQEAVRWTEM
-
Molecular Weight
20 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPAG9, or Sperm Associated Antigen 9, is a protein previously identified in the context of male reproduction, where it is expressed in spermatozoa and has been implicated in sperm motility and function. Research indicates that SPAG9 may play a role in the intricate molecular mechanisms governing sperm-egg interaction and fertilization. The study of SPAG9 is particularly relevant in the field of reproductive biology and infertility, as anomalies in sperm function are a significant factor contributing to male infertility. Furthermore, recent investigations suggest that SPAG9 might have potential applications in developing diagnostic tools or therapeutic strategies for male reproductive disorders. Given its expression in cancerous tissues as well, SPAG9 has gained attention as a potential biomarker and therapeutic target in oncology, expanding its relevance beyond reproductive health. This dual role in both reproduction and cancer highlights the need for comprehensive studies on SPAG9's structure, function, and regulatory mechanisms. Understanding the molecular properties and interactions of SPAG9 through recombinant protein studies could provide valuable insights into its biological significance, paving the way for innovative clinical applications, including the development of novel fertility treatments and cancer interventions. As a result, SPAG9 recombinant protein research not only contributes to our understanding of male reproductive health but also offers potential therapeutic avenues across various medical domains.
